FindTrial
Sign In

Prostate cancer and bone health

A prospective study to evaluate bone health, FRAX score and quality of life in patients of carcinoma prostate.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/08/009451
Enrollment
80
Registered
2017-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Prostate cancer patients who presents to KGMU for treatment will be enrolled in the study.

Interventions

None listed

Sponsors

King George Medical University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed cases of prostate cancer

Exclusion criteria

Exclusion criteria: 1.Other active malignancy 2.Metabolic bone disease

Design outcomes

Primary

MeasureTime frame
1.To evaluate the bone health, FRAX score and quality of life in carcinoma prostate patients. 2. To reduce their morbidity related to carcinoma prostate by delaying skeletal related events and to improve overall quality of life. Timepoint: between january 2017 to december 2018—

Secondary

MeasureTime frame
1.To evaluate mortality and morbidity in prostate cancer patients. 2. To evaluate adverse events related to androgen deprivation therapy.Timepoint: between january 2017 to december 2018—

Countries

India

Contacts

Public ContactDr Ashish Sharma

King George Medical University

rahuljanaksinha@gmail.com9554952051

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026